Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study.

Blood
Jeppe FrederiksenBørge Grønne Nordestgaard

Abstract

Hyperhomocysteinemia is associated with ischemic cardiovascular disease (ICD) and venous thromboembolism (VTE). We tested the hypothesis that methylenetetrahydrofolate reductase (MTHFR) C677T homozygosity with hyperhomocysteinemia is associated with ICD and VTE. First, 9238 randomly selected whites from the general population were followed for 23 years. Second, 2125 whites with ischemic heart disease and 836 whites with ischemic cerebrovascular disease were compared with 7568 controls from the general population. Plasma homocysteine was elevated 25% in homozygotes versus noncarriers (P < .001) and 19% in ICD/VTE cases versus controls (P < .001). In prospective studies adjusted hazard ratios for ICD and VTE for homozygotes versus noncarriers did not differ from 1.0. Furthermore, MTHFR C677T homozygosity was not associated with increased risk of ICD or VTE in subgroups after stratification for sex, age, cholesterol, high-density lipoprotein cholesterol, lipoprotein(a), fibrinogen, triglycerides, body mass index, smoking, diabetes mellitus, hypertension, and factor V Leiden genotype. Finally, in case-control studies odds ratios for ischemic heart disease and ischemic cerebrovascular disease in homozygotes versus noncarriers did no...Continue Reading

References

Dec 3, 1999·Journal of Internal Medicine·O NygårdP M Ueland
Mar 1, 2000·Archives of Internal Medicine·W G ChristenC H Hennekens
Aug 2, 2000·The American Journal of Clinical Nutrition·L Brattström, D E Wilcken
May 17, 2002·The American Journal of Medicine·Arduino A Mangoni, Stephen H D Jackson
Jun 19, 2002·Blood·Klaus JuulBørge Grønne Nordestgaard
Oct 26, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN Homocysteine Studies Collaboration
Oct 22, 2002·JAMA : the Journal of the American Medical Association·Mariska KlerkUNKNOWN MTHFR Studies Collaboration Group
Oct 24, 2002·Journal of Clinical Epidemiology·Leonelo E BautistaLuz X Martínez
Nov 26, 2002·BMJ : British Medical Journal·David S WaldJoan K Morris

❮ Previous
Next ❯

Citations

Feb 14, 2006·Journal of Thrombosis and Thrombolysis·Stephan Moll
Dec 25, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Filippo AucellaUNKNOWN Genetic Polymorphisms in Dialysis Study Group
Oct 4, 2005·The Cancer Journal·Lisa Bomgaars, Howard L McLeod
May 10, 2005·BMJ : British Medical Journal·Tom FaheyShah Ebrahim
May 10, 2005·BMJ : British Medical Journal·George Davey Smith, Shah Ebrahim
Nov 18, 2010·Anesthesia and Analgesia·Roman M SniecinskiJerrold H Levy
Dec 22, 2006·PloS One·Domenico GirelliRoberto Corrocher
May 10, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Maria Grazia AndreassiSilvia Maffei
Jan 6, 2006·Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology·Armando Tripodi
Jan 30, 2013·International Journal of Molecular Sciences·Seyyed Reza PishvaMohammad Reza Sabri
Apr 23, 2008·European Journal of Endocrinology·Sarah J LewisGeorge Davey Smith
Oct 25, 2011·Annual Review of Pathology·Andrew G Muntean, Jay L Hess
Apr 12, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·José Ramón González-PorrasJesús San Miguel
Oct 31, 2009·Journal of Vascular and Interventional Radiology : JVIR·Karim Valji, Michael Linenberger
Aug 15, 2015·Thrombosis and Haemostasis·Massimo FranchiniPier Mannuccio Mannucci
Sep 22, 2009·The Journal of Molecular Diagnostics : JMD·Shannon D BarkerLisa V Kalman
Feb 24, 2015·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Charles J GlueckPing Wang
Apr 9, 2015·Acta Diabetologica·Fulvio PomeroFrancesco Dentali
Jun 11, 2005·Journal of Thrombosis and Haemostasis : JTH·A J C SlooterA Algra
Apr 28, 2005·International Journal of Clinical Practice·P PudduA Muscari
May 21, 2009·Journal of Thrombosis and Haemostasis : JTH·S K BraekkanJ B Hansen
Jul 31, 2008·Journal of Thrombosis and Haemostasis : JTH·S K BraekkanJ B Hansen
Jun 3, 2006·Obesity·Tuomo RankinenClaude Bouchard
Jan 3, 2013·Journal of Thrombosis and Haemostasis : JTH·P Brøndum-JacobsenB G Nordestgaard
Jul 4, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Gjin NdrepepaAlbert Schömig
Jul 22, 2015·Genetic Testing and Molecular Biomarkers·Nasir A S Al-AllawiNajat T M Al-Mzury
Nov 1, 2011·Atherosclerosis·Aurélien DellucKarine Lacut
Dec 3, 2014·European Journal of Medical Genetics·Siaw-Cheok Liew, Esha Das Gupta
Jul 15, 2016·Nature Reviews. Rheumatology·Philip C RobinsonTony R Merriman
Apr 26, 2007·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Sibel KabukcuErol Atalay
Mar 31, 2018·Molecular Biology Reports·Shahnaz IbrahimRaheel Qamar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.